Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06434402 · ClinicalTrials.gov registry record · NA

A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

A NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06434402: Recruiting NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

NCT06434402 is a NA study of Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06434402, a NA study of Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To learn more about the experiences of adolescent and young adult cancer survivors and investigate whether a group-based writing intervention can help to improve quality of life of adolescent and young adult cancer survivors.

Primary Outcome

The Study completion rate is defined as the average proportion of participants who complete follow-up assessments at 1-month follow-up. We will also calculate the 95% confidence intervals for the study completion rate.

Conditions Studied

Cancer

Interventions

  • BEHAVIORAL Behavioral Intervention

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-05-22
Est. Completion 2026-09-01
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What NCT06434402 shows while recruiting

NCT06434402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Intervention is the first listed.

NCT06434402 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06434402 about?

NCT06434402 is a clinical study titled "A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer". To learn more about the experiences of adolescent and young adult cancer survivors and investigate whether a group-based writing intervention can help to improve quality of life of adolescent and young adult cancer survivors.

What is the current status of trial NCT06434402?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-22. Estimated completion is 2026-09-01.

What conditions does trial NCT06434402 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06434402?

The interventions under investigation include: Behavioral Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06434402?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06434402 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06434402's enrollment target sits among peer trials

30 502nd of 615 higher than 93 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06434402

Source: ClinicalTrials.gov NCT06434402, the US trial registry maintained by the National Library of Medicine. NCT06434402 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.